NCT04845503View on ClinicalTrials.gov

Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

March 25, 2023

Study Completion Date

March 25, 2028

Conditions
Prostate Cancer
Interventions
RADIATION

MR-guided Radiotherapy

Total Dose 37,5 Gy, Single Dose 7,5 Gy, 5 Fractions applied in 1-2 weeks

Trial Locations (1)

69120

University Hospital of Heidelberg, Radiation Oncology, Heidelberg

All Listed Sponsors
collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

University Hospital, Zürich

OTHER

lead

University Hospital Heidelberg

OTHER